These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4835097)

  • 21. Role of delayed hypersensitivity in predicting postoperative morbidity and mortality.
    Johnson WC; Ulrich F; Mequid MM; Lepak N; Bowe P; Harris P; Alberts LH; Nabseth DC
    Am J Surg; 1979 Apr; 137(4):536-42. PubMed ID: 426204
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity and MuMTV-like antigenicity of human breast cancer tissues.
    Black MM
    Contemp Top Immunobiol; 1977; 6():239-62. PubMed ID: 194749
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation of delayed hypersensitivity and leukocyte migration inhibition factor in the serum of cancer patients.
    Botto HG; Gauthier H; Pouillart P; Bruley-Rosset M; Huguenin P
    Eur J Cancer (1965); 1977; 13(4-5):329-32. PubMed ID: 194777
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 3. The frequency, duration, and cross reactivity of this phenomenon in patients with breast cancer, and its correlation with survival.
    Stewart TH; Orizaga M
    Cancer; 1971 Dec; 28(6):1472-8. PubMed ID: 5127795
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
    McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
    J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 30. Human leukocyte migration inhibition as an indicator of cellular hypersensitivity to soluble antigens.
    Rauch HC; King K
    Int Arch Allergy Appl Immunol; 1973; 44(6):862-74. PubMed ID: 4199134
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anamnestic immune response in patients with breast cancer].
    Eljuga D; Rogan-Grgas J; Vujicić N; Nola P; Malenica B
    Lijec Vjesn; 1985 May; 107(5):181-3. PubMed ID: 4010446
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    Surg Forum; 1978; 29():167-9. PubMed ID: 233830
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Suppression of delayed hypersensitivity in Graves' disease.
    Joasoo A; Penny R
    Lancet; 1974 Aug; 2(7875):291-2. PubMed ID: 4135718
    [No Abstract]   [Full Text] [Related]  

  • 34. Properties of tumor-specific antigen solubilized by hypertonic potassium chloride.
    Leonard EJ; Meltzer MS; Borsos T; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():129-34. PubMed ID: 4572822
    [No Abstract]   [Full Text] [Related]  

  • 35. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.
    Alford C; Hollinshead AC; Heberman RB
    Ann Surg; 1973 Jul; 178(1):20-4. PubMed ID: 4717706
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed skin hypersensitivity reaction in normal children.
    Kerr AA; Denton RG
    N Z Med J; 1978 Jul; 88(616):57-9. PubMed ID: 360117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
    Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
    Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of anti-immunoglobulin sera on migration inhibition mediated by human lymphocytes.
    Marsman AJ; van der Hart M
    Eur J Immunol; 1974 Apr; 4(4):235-40. PubMed ID: 4859298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.